ArticleBMC palliative care2017
Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history.
Article in BMC palliative care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 107 citations in OpenAlex.
- Trial
- Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up.International journal of environmental research and public health · 2020Trial
- Exploratory cost-effectiveness analysis ofClinical & experimental metastasis · 2020Trial
- Population Preferences for Treatment in Life-Limiting Illness: Valuing the Way Time Is Spent at the End of Life.Medical decision making : an international journal of the Society for Medical Decision Making · 2025Article
- The correlation between anger/agitation and other factors including spousal care in home-dwelling older adults with advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Out-of-pocket costs for patients diagnosed with high-grade glioma and their carers.Neuro-oncology practice · 2025Article
- Cost profiles of cancer patients at the end of life: Estimates from the EPICOST-study.PloS one · 2025Article
- Healthcare use and costs in the last six months of life by level of care and cause of death.BMC health services research · 2024Article
- Exploring End-of-Life Care for Patients with Breast Cancer, Dementia or Heart Failure: A Register-Based Study of Individual and Institutional Factors.Healthcare (Basel, Switzerland) · 2024Article
- Primary care usage at the end of life: a retrospective cohort study of cancer patients using linked primary and hospital care data.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Article
- Potentially burdensome care at the end-of-life for cancer decedents: a retrospective population-wide study.BMC palliative care · 2024Article
- Financial toxicity in cancer palliative care in India: Addressing existence and beyond - Seeking remedies for a balanced financial journey.Ecancermedicalscience · 2024Article
- Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease.PharmacoEconomics - open · 2023Article
- Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark.PharmacoEconomics - open · 2023Article
- Comparison of functional disabilities, place of death and end-of-life medical expenditures among centenarians and non-centenarians in China: a series of cross-sectional studies.BMC geriatrics · 2023Article
- Article
- Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study.BMC palliative care · 2023Article
- Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling study.BMC health services research · 2023Article
- Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data.Cancer medicine · 2023Article
- Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-based Palliative Care: Scoping Review.Journal of medical Internet research · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is limited population-level research on end-of-life care in Australia that considers health care use and costs across hospital and community sectors. The aim of this study was to quantify health care use and costs in the last 6 months of life in a cohort of elderly Australian decedents and to examine the factors associated with end-of-life resource use and costs.
methodsA retrospective cohort study using routinely collected health data from Australian Government Department of Veterans' Affairs clients. The study included two cohorts of elderly Australians who died between 2005 and 2009; one cohort with a recorded cancer diagnosis and a comparison cohort with no evidence of a cancer history. We examined hospitalisations, emergency department (ED) visits, prescription drugs, clinician visits, pathology, and procedures and associated costs in the last 6 months of life. We used negative binominal regression to explore factors associated with health service use and costs.
resultsThe cancer cohort had significantly higher rates of health service use and 27% higher total health care costs than the comparison cohort; in both cohorts, costs were driven primarily by hospitalisations. Older age was associated with lower costs and those who died in residential aged care incurred half the costs of those who died in hospital.
conclusionsThe results suggest differences in end-of-life care pathways dependent on patient factors, with younger, community-dwelling patients and those with a history of cancer incurring significantly greater costs. There is a need to examine whether the investment in end-of-life care meets patient and societal needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.